Why Lite Strategy, Inc.’s (LITS) Stock Is Down 6.41%
As of Thursday, January 15, Lite Strategy, Inc.’s LITS share price has dipped by 6.41%, which has investors questioning if this is right time to buy.Cynthia McLaughlin
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. The company was formerly known as MEI Pharma, Inc. and changed its name to Lite Strategy, Inc. in September 2025. Lite Strategy, Inc. was incorporated in 2000 and is based in San Diego, California.
Commentary & Analysis
Why Lite Strategy, Inc.’s (LITS) Stock Is Up 7.72%
As of Wednesday, January 14, Lite Strategy, Inc.’s LITS share price has surged by 7.72%, which has investors questioning if this is right time to sell.Cynthia McLaughlin
Why Lite Strategy, Inc.’s (LITS) Stock Is Down 5.10%
As of Monday, January 12, Lite Strategy, Inc.’s LITS share price has dipped by 5.10%, which has investors questioning if this is right time to buy.Jenna Brashear
Why Lite Strategy, Inc.’s (LITS) Stock Is Down 5.20%
As of Wednesday, January 07, Lite Strategy, Inc.’s LITS share price has dipped by 5.20%, which has investors questioning if this is right time to buy.Jenna Brashear
Why Lite Strategy, Inc.’s (LITS) Stock Is Down 6.47%
As of Friday, December 26, Lite Strategy, Inc.’s LITS share price has dipped by 6.47%, which has investors questioning if this is right time to buy.Cynthia McLaughlin
Financial Summary
| Share Statistics | LITS | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $35.4 | $288.9 | 13% |
|
| Shares Out (Mil) | 35.7 | 54.0 | 40% |
|
| Institutional Ownership | 93.4% | 93.1% | 63% |
|
| Float (Mil) | 31.8 | 41.4 | 37% |
|
| Beta | 0.04 | 0.94 | 7% |
|
| Avg Daily Volume (000s) | 189 | 480 | 45% |
|
| Price Change (52-week) |
(78.6%) | 59.9% | 7% |
|
| Growth | LITS | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 14.1% | na |
|
| Net Income (5yr) | 19.6% | (10.1%) | 72% |
|
| EPS (5yr) | 25.4% | 15.9% | 76 |
|
| Dividends (5yr) | na | 0.0% | na |
|
| Cash Flow (5yr) | 29.1% | (15.6%) | 85% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | LITS | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | na | $37 | na |
|
| Net Income (TTM) (Mil) | ($61) | ($43) | 15% |
|
| EPS (TTM) | ($2.206) | ($1.500) | 14% |
|
| Operating Cash Flow (TTM) (Mil) | ($10) | ($31) | 20% |
|
| Net Cash Flow (TTM) (Mil) | na | $2 | na |
|
| Long-Term Debt (Q1) (Mil) | $0 | $4 | 0% |
|
| Enterprise Value (Q1) (Mil) | $21 | $190 | 11% |
|
| Valuation | LITS | Industry Median |
Percentile (All Stocks) |
|
| P/B | 0.64 | 2.84 | 11% |
|
| P/E | na | 20.0 | na |
|
| Dividend Yield | na | 0.0% | na |
|
| PEG (5yr hist) | na | 1.1 | na |
|
| Ratios | LITS | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | na | 66.9% | na |
|
| Net Margin | na | (74.2%) | na |
|
| ROA | (154.8%) | (47.7%) | 3% |
|
| ROE | (159.3%) | (55.0%) | 5% |
|
| Liabilities to Assets | 1.6% | 29.6% | 0% |
|
| F-Score | 1 | 3 | 1% |
|
Lite Strategy, Inc. did not pass any screens on 9/2/2026.
